Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NRX | Common Stock | Exercise of in-the-money or at-the-money derivative security | $200 | +40K | +8.11% | $0.01* | 533K | Dec 28, 2023 | Direct | |
transaction | NRX | Common Stock | Sale | -$198 | -76 | -0.01% | $2.61 | 533K | Dec 28, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NRX | Warrant (right to purchase) | Exercise of in-the-money or at-the-money derivative security | $0 | -40K | -100% | $0.00* | 0 | Dec 28, 2023 | Common Stock | 40K | $0.01 | Direct |
Id | Content |
---|---|
F1 | On December 28, 2023, the reporting person exercised a warrant to purchase 40,000 shares of Neuraxis, Inc. (the "Company") common stock for $0.005 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Company withholding 76 of the warrant shares to pay the exercise price and issuing the reporting person the remaining 39,924 shares. |